What’s Going On Here? China’s Hansoh Pharmaceutical raised $1 billion from its initial public offering – Hong Kong’s second-biggest this year – valuing the company at over $10 billion. Initial public offering is a company’s flotation on the stock exchange. What Does This Mean? Hansoh’s drug portfolio made up 63% of the entire Chinese pharmaceutical market last year – and includes…